vs
GEN Restaurant Group, Inc.（GENK）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
GEN Restaurant Group, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.4倍（$49.7M vs $35.5M），GEN Restaurant Group, Inc.净利率更高（-3.8% vs -304.2%，领先300.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -9.0%），GEN Restaurant Group, Inc.自由现金流更多（$-5.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -1.0%）
GEN韩式烤肉是美国的韩式烤肉自助连锁品牌，门店主要集中于美国西部地区，品牌创立于2011年，截至2024年已发展至43家门店，主打任食韩式烤肉产品，在当地拥有较高的知名度。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GENK vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.7M | $35.5M |
| 净利润 | $-1.9M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -24.5% | -304.8% |
| 净利率 | -3.8% | -304.2% |
| 营收同比 | -9.0% | 681.7% |
| 净利润同比 | -821.4% | 39.6% |
| 每股收益（稀释后） | $-0.37 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $49.7M | $35.5M | ||
| Q3 25 | $50.4M | $5.2M | ||
| Q2 25 | $55.0M | $19.2M | ||
| Q1 25 | $57.3M | $14.7M | ||
| Q4 24 | $54.7M | $4.5M | ||
| Q3 24 | $49.1M | $26.1M | ||
| Q2 24 | $53.9M | $14.4M | ||
| Q1 24 | $50.8M | $13.8M |
| Q4 25 | $-1.9M | $-108.1M | ||
| Q3 25 | $-566.0K | $-162.3M | ||
| Q2 25 | $-261.0K | $-171.9M | ||
| Q1 25 | $-301.0K | $-202.5M | ||
| Q4 24 | $-206.0K | $-178.9M | ||
| Q3 24 | $25.0K | $-95.8M | ||
| Q2 24 | $277.0K | $-97.5M | ||
| Q1 24 | $496.0K | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -24.5% | -304.8% | ||
| Q3 25 | -7.4% | -3327.6% | ||
| Q2 25 | -3.4% | -916.8% | ||
| Q1 25 | -3.8% | -1297.9% | ||
| Q4 24 | -2.4% | -4042.4% | ||
| Q3 24 | 0.2% | -377.1% | ||
| Q2 24 | 3.0% | -697.4% | ||
| Q1 24 | 0.2% | -698.4% |
| Q4 25 | -3.8% | -304.2% | ||
| Q3 25 | -1.1% | -3135.3% | ||
| Q2 25 | -0.5% | -894.2% | ||
| Q1 25 | -0.5% | -1373.3% | ||
| Q4 24 | -0.4% | -3935.5% | ||
| Q3 24 | 0.1% | -367.5% | ||
| Q2 24 | 0.5% | -676.6% | ||
| Q1 24 | 1.0% | -662.4% |
| Q4 25 | $-0.37 | $-0.17 | ||
| Q3 25 | $-0.11 | $-0.36 | ||
| Q2 25 | $-0.05 | $-0.41 | ||
| Q1 25 | $-0.06 | $-0.50 | ||
| Q4 24 | $-0.05 | $-0.56 | ||
| Q3 24 | $0.01 | $-0.34 | ||
| Q2 24 | $0.06 | $-0.40 | ||
| Q1 24 | $0.11 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.8M | $743.3M |
| 总债务越低越好 | $13.6M | $9.6M |
| 股东权益账面价值 | $26.5M | $1.1B |
| 总资产 | $259.9M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.51× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $2.8M | $743.3M | ||
| Q3 25 | $4.8M | $659.8M | ||
| Q2 25 | $9.6M | $525.1M | ||
| Q1 25 | $15.4M | $500.5M | ||
| Q4 24 | $23.7M | $594.4M | ||
| Q3 24 | $22.1M | $427.6M | ||
| Q2 24 | $29.2M | $474.3M | ||
| Q1 24 | $28.1M | $296.3M |
| Q4 25 | $13.6M | $9.6M | ||
| Q3 25 | $10.8M | $11.9M | ||
| Q2 25 | $7.8M | $14.2M | ||
| Q1 25 | $6.5M | $16.4M | ||
| Q4 24 | $6.9M | $19.0M | ||
| Q3 24 | $7.2M | $20.5M | ||
| Q2 24 | $7.6M | $22.9M | ||
| Q1 24 | $7.7M | — |
| Q4 25 | $26.5M | $1.1B | ||
| Q3 25 | $38.1M | $1.0B | ||
| Q2 25 | $41.0M | $919.1M | ||
| Q1 25 | $42.8M | $933.9M | ||
| Q4 24 | $44.1M | $1.0B | ||
| Q3 24 | $46.5M | $524.6M | ||
| Q2 24 | $45.9M | $584.4M | ||
| Q1 24 | $40.4M | $401.2M |
| Q4 25 | $259.9M | $1.5B | ||
| Q3 25 | $245.5M | $1.4B | ||
| Q2 25 | $246.3M | $1.3B | ||
| Q1 25 | $232.4M | $1.3B | ||
| Q4 24 | $240.4M | $1.4B | ||
| Q3 24 | $225.7M | $726.5M | ||
| Q2 24 | $218.8M | $775.9M | ||
| Q1 24 | $214.5M | $557.8M |
| Q4 25 | 0.51× | 0.01× | ||
| Q3 25 | 0.28× | 0.01× | ||
| Q2 25 | 0.19× | 0.02× | ||
| Q1 25 | 0.15× | 0.02× | ||
| Q4 24 | 0.16× | 0.02× | ||
| Q3 24 | 0.16× | 0.04× | ||
| Q2 24 | 0.17× | 0.04× | ||
| Q1 24 | 0.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-426.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-5.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | -11.3% | -133.1% |
| 资本支出强度资本支出/营收 | 10.5% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-24.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-426.0K | $-46.1M | ||
| Q3 25 | $-1.6M | $-117.4M | ||
| Q2 25 | $3.3M | $-76.4M | ||
| Q1 25 | $2.2M | $-132.0M | ||
| Q4 24 | $7.3M | $-115.4M | ||
| Q3 24 | $1.4M | $-59.2M | ||
| Q2 24 | $5.6M | $-82.2M | ||
| Q1 24 | $3.5M | $-102.3M |
| Q4 25 | $-5.6M | $-47.3M | ||
| Q3 25 | $-7.7M | $-117.6M | ||
| Q2 25 | $-6.3M | $-79.6M | ||
| Q1 25 | $-4.7M | $-133.8M | ||
| Q4 24 | $165.0K | $-116.7M | ||
| Q3 24 | $-6.8M | $-63.8M | ||
| Q2 24 | $1.2M | $-83.4M | ||
| Q1 24 | $-586.0K | $-109.0M |
| Q4 25 | -11.3% | -133.1% | ||
| Q3 25 | -15.3% | -2272.5% | ||
| Q2 25 | -11.5% | -413.9% | ||
| Q1 25 | -8.2% | -907.4% | ||
| Q4 24 | 0.3% | -2567.7% | ||
| Q3 24 | -13.9% | -244.6% | ||
| Q2 24 | 2.3% | -578.5% | ||
| Q1 24 | -1.2% | -789.9% |
| Q4 25 | 10.5% | 3.5% | ||
| Q3 25 | 12.0% | 4.7% | ||
| Q2 25 | 17.5% | 16.4% | ||
| Q1 25 | 11.9% | 12.4% | ||
| Q4 24 | 13.1% | 28.6% | ||
| Q3 24 | 16.9% | 17.5% | ||
| Q2 24 | 8.0% | 8.2% | ||
| Q1 24 | 8.1% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 57.96× | — | ||
| Q2 24 | 20.06× | — | ||
| Q1 24 | 7.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
